Hemimegalencephaly with intractable epilepsy: A case report by Chand, Prem et al.
eCommons@AKU
Department of Paediatrics and Child Health Division of Woman and Child Health
September 2017
Hemimegalencephaly with intractable epilepsy: A
case report
Prem Chand





Follow this and additional works at: http://ecommons.aku.edu/
pakistan_fhs_mc_women_childhealth_paediatr
Part of the Neurology Commons, and the Pediatrics Commons
Recommended Citation
Chand, P., Raghib, M. F., Salat, M. S. (2017). Hemimegalencephaly with intractable epilepsy: A case report. Journal of the Pakistan
Medical Association:JPMA, 67(9), 1444-1446.
Available at: http://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_paediatr/272
Abstract
Isolated Hemimegalencephaly (iHME) is a rare form of
congenital malformation of cortical development.  It is
characterized by enlargement of all or part of one cerebral
hemisphere. It typically presents with intractable seizures,
mental retardation, developmental delay, contralateral
hemiparesis and hemianopia. The patient was a five and
half month's old baby girl who presented first with focal
seizures at 10th day of life. No other physical or behavioral
abnormality was noted. However, Initial EEG showed
excessive sharp EEG transients more over the right
hemisphere, repeated EEG showed spikes, polyspikes,
sharps and slow wave discharges  predominately over
right hemisphere. MRI brain showed asymmetric
enlargement of the right cerebral hemisphere, suggestive
of hemimegalencephaly. Initial treatment with anti-
epileptics was successful in controlling the seizures but
later on the seizures became intractable even on
polytherapy. Identification of this and similar cases of
iHME can help us better understand this disorder and its
associated symptoms and eventually help us develop




Hemimegalencephaly (HME) is a rare congenital
malformation of cortical development characterized by
enlargement of all or part of one cerebral hemisphere.1
HME may occur as an isolated disease or as a part of
Proteus syndrome, neurofibromatosis, linear sebaceous
nevus syndrome, tuberous sclerosis complex, or Klippel-
Weber-Trenaunay syndrome.2 The typical characteristics
of isolated hemimegalencephaly (iHME) include
ipsilateral severe cortical dysplasia or dysgenesis, white
matter hypertrophy and a dilated and dysmorphic lateral
ventricle.3 This asymmetric and enlarged brain tissue is
associated with intractable seizures, developmental delay,
contralateral hemiparesis, and hemianopia.4 Because
there is no cure for iHME, the principal aim of the
treatment of this disease is to control seizures, which is
done by using a variety of anti-epileptic drugs.4 However,
in majority of patients the seizures remain intractable and
hemispherectomy is the treatment of choice.4 Even
though this surgical procedure has been shown to be
successful in reducing the frequency of seizures, the risks
of morbidity, which includes hydrocephalus, intracranial
haematomas and infections, remain high.3
Cases of iHME present as sporadic cases and do not show
familial inheritance or sex preference.2 This fact makes it
very difficult to identify a particular genetic etiology for
iHME. Nevertheless, different studies have shown
association between iHME and mutations in AKT3, PIK3CA
and MTOR genes. 2It has also been reported that Pitx2,
lefty-1, lefty-2 and Zic3 genes play a role in asymmetric
growth pattern of brain hemisphere.5 Therefore, it is
important that more cases of iHME are identified and
reported so that further research can be conducted to
understand this disorder and develop better treatment
strategy.  There are only few cases of iHME has been
reported from Pakistan.
Case Report
A five and half month's old baby girl presented to the Aga
Khan University Hospital in January 2016 with history of
focal seizures since 10th day of life. Her seizures consisted
of jerky movement localized to the left side of the body
with up-rolling of eyes and excessive crying. No other
symptoms were noted. The child was born via
spontaneous vaginal delivery after 40 weeks of normal
gestation period. Upon examination at the time of birth
the child had a visible right sided cephalhaematoma. The
head circumference was 34 cm and body weight was 2.8
kg. She was the only child of non-consanguineous
parents. There was no history of miscarriage or syndromic
baby in either parent's family.
Initial workup included EEG, which showed excessive
sharp EEG transients more over the right hemisphere and
MRI brain, which showed asymmetric enlargement of the
right cerebral hemisphere and diffuse thickening of
cortical grey matter with increased myelination over right
hemisphere, suggestive of right sided
hemimegalencephaly (Figure-1). Initially her seizures
were well controlled with phenobarbital.
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The child again presented at the age of five and half
months in the emergency room with multiple left sided
focal seizures. This time a paucity of movement over left
sided body was also noted. The head circumference was
37.5 cm, weight 5.5 kg and height was 58 cm. She had
partial neck holding, could reach out objects and coos. No
dysmorphic features or skin manifestation were noted
and she did not present with any syndromic features.
Another EEG was done which showed right sided
dominant spikes, polyspikes, sharps and slow wave
discharges (Figure-2). Her seizures were difficult to control
with first line of antiepileptics, so Levetiracetam and
Topiramate were added to the management. Treatment
option of surgical intervention was also discussed with
the parents.
Discussion
Malformations of cortical development arise due to
disruption in the proliferation, migration or post-
migration stages during the development of cortex.6
Disruption in any of these processes can cause seizures
and neurodevelopmental delay in children.6
Hemimegalencephaly, characterized by hamartomatous
growth of a cerebral hemisphere, has been categorized
under the term of "cortical dysgenesis" owing to disorders
of proliferation.7
Hemimegalencephaly is categorized into three types:
Isolated, syndromic and total.8 Isolated
hemimegalencephaly has no associated hemicorporal
hypertrophy or cutaneous or systemic involvement.
Syndromic hemimegalencephaly (for example, epidermal
nevus syndrome and Proteus Syndrome) is associated
with other features which include hemicorporal
hypertrophy of the ipsilateral part of the body. Total
hemimegalencephaly, which is the least common form,
also involves enlargement of the brainstem and
cerebellum. Cases of syndromic hemimegalencephaly
have been reported from Pakistan previously, however,
here we are reporting the first case of isolated
hemimegalencephaly from our institute after receiving
consent from the parents. 
Previous studies have shown that
mutations in AKT3, PIK3CA and
mTOR genes are associated with
iHME.2 In particular, the
association of the modulation of
mTOR signaling cascade and
iHME has been the focus of many
studies.9 Some studies suggest
that mTOR activation itself can
produce nerve cell excitability
and this can be helpful in
explaining why patients with
iHME have seizures.9 These
findings show that further
research needs to be conducted
on iHME, not only to better
understand this disorder but also
to develop better treatment
Vol. 67, No. 9, September 2017
Hemimegalencephaly with intractable epilepsy: A case report 1445
Figure-1: MRI showing transverse view of the brain. Hemimegalencephaly of the right
side of brain can be easily identified. A cephalhaematoma can also be seen on the right.
Figure-2: EEG recording showspredominantly right sided spike, polyspikes and wave discharges.
options for these patients.
Conclusion
Here we have presented a rare case report of iHME with
intractable epilepsy. Identification of this and other similar
cases can allow us to conduct further research on this rare
disease. Findings of these studies will not only improve
the treatment options for iHME but they can also help us
understand the mechanism of its symptoms. Hence, these
findings can improve our understanding of other
disorders which share similar symptoms.
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